Citing Safety Reasons, Eli Lilly Halts COVID Treatment Trial
Citing Safety Reasons, Eli Lilly Halts COVID Treatment Trial

Drug maker Eli Lilly is hitting pause on a clinical trial for a coronavirus treatment; CBS2's Dick Brennan reports.